Clinical pharmacists' interventions reduce drug related problems including medication errors and drug related events in neurology and in other medical specialities Difficulties exist in evaluating an economic benefit of pharmacists' interventions or implemented measures So far there are no published data that show an economic benefit of pharmacists' interventions in IVIG-therapy nor in neurology What does this study add? Clinical pharmacists reduce drug costs, increase drug related proceeds and reduce length of stay regarding neurological patients treated with immunoglobulins This method can be applied in other case scenarios with high treatment costs or special terms of reimbursement to show an economic benefit of interventions Further studies are needed to evolve a less time-consuming method to quantify an economic benefit in all possible scenarios 
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DISCUSSION
To our knowledge this is the first report about the economic benefit of clinical pharmacists' interventions in IVIG-therapy in neurology. This method can be used in future for other drugs with high treatment costs or with special terms of reimbursement. Main deficiency of this method is, that the economic benefit of decreased length of stay is only calculated. However, the biggest savings were achieved by selection of IVIG, interventions to dose and duration of treatment and documentation to ensure best possible proceeds. Based on these results it is important to integrate clinical pharmacists in daily routine on neurological wards.
CONCLUSION
Clinical pharmacists should be well integrated in daily clinical practice of neurological wards in order to reduce costs, decrease length of stay and increase proceeds. 
Causal nexus of strategic and case-related measures

PURPOSE
The aim of this work is to capture the economic benefit of pharmacists' interventions under consideration of the German reimbursement system.
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